Abstract
In Australia, Middle Eastern refugees, notably the Ezidi community (an ethnic and religious minority from Northern Iraq and Syria) are disproportionately affected by high rates of vitamin and iron deficiencies. These deficiencies pose significant health risks and can impact overall well-being. Recent studies have suggested a possible correlation between Helicobacter pylori (H. pylori) infection and deficiencies in essential vitamins and iron, highlighting an important area of research that warrants further exploration. Understanding the relationship between H. pylori infection and nutrient deficiencies in newly arrived Ezidi refugees is critical for several reasons. First, it may provide insights into the underlying health challenges faced by this population, who often arrive with pre-existing health issues. Second, establishing this association could inform current screening practices, allowing for targeted interventions that address both H. pylori infection and nutritional deficiencies. Ultimately, this research aims to contribute to the development of effective health strategies that enhance the well-being of Ezidi refugees, ensuring they receive the necessary support to thrive in their new environment. By focusing on this intersection of infectious disease and nutritional health, we can better understand and mitigate the risks faced by this vulnerable group. A retrospective cohort study was performed using data collected from Ezidi refugees in Armidale Medical Centre and Armidale Hospital from 2018 to 2024. The data was analysed to determine the prevalence of H. pylori and deficiencies in iron, vitamin B12, and vitamin D. Further analysis was done with data from Armidale Medical Center only, to study any potential association between H. pylori infection and those same micronutrient deficiencies. H. pylori infection was detected in 76.7% of refugees tested. The rates of iron deficiency were 35.2% at Armidale Medical Centre and 41.9% at Armidale Hospital. Vitamin B12 deficiency was found in 50.7% and 58% of individuals, and vitamin D deficiency was present in 79.6% and 82.6%, respectively. No statistically significant associations were found between H. pylori infection and iron or vitamin D deficiency. However, a statistically significant association was observed between the absence of H. pylori and vitamin B12 deficiency. There is a significantly higher prevalence of H. pylori infection, iron deficiency, vitamin B12 deficiency, and vitamin D deficiency among Ezidi refugees in Armidale. The relationship between H. pylori infection and micronutrient deficiencies remains unclear. Further research is needed to clarify these associations and guide future screening protocols for Ezidi refugees.
Keywords: Helicobacter pylori, Ezidi refugees, Vitamin B12 and D, Iron
Background
Helicobacter pylori (H. pylori) is a gram-negative, rod-shaped bacteria that infects the stomach’s lining (1) and is one of the most common bacterial infections globally. H. pylori infection is associated with several gastrointestinal diseases, including chronic gastritis, gastric and duodenal ulcers, and in more severe cases, gastric cancer or mucosa-associated lymphoid tissue (MALT) lymphoma(2). Studies have demonstrated that H. pylori eradication can lower the incidence of gastric cancer (2, 3).
Helicobacter pylori infections have also been associated with micronutrient deficiencies, especially in populations with pre-existing health disparities like refugees. Refugees face a higher risk of malnutrition and micronutrient deficiencies due to factors such as inadequate access to food, displacement, acculturation challenges, and limited access to healthcare(4, 5). Middle Eastern countries have a higher incidence of vitamin B12, vitamin D, and iron deficiencies(6). Given the high prevalence of these deficiencies among Middle Eastern refugees in Australia, a rate notably higher than the estimated prevalence of iron deficiency in the Australian population, which affects approximately 3.3% of adults (7), it is reasonable to assume that they might also affect Ezidi individuals, a subgroup of refugees from Iraq and Syria.
The biological mechanisms behind micronutrient deficiencies are not fully understood but several potential factors have been proposed. These include intestinal bleeding, atrophic gastritis, hepcidin upregulation, and long-term autoimmune changes(8, 9). A recent meta-analysis (10) suggested negative effects of H. pylori infection on serum vitamin B12, folate, vitamin C, and vitamin D levels. While the impact of H. pylori infection on serum vitamin D levels remains unclear, there is evidence that vitamin D supplementation can positively influence the efficacy of H. pylori eradication therapy(9, 11, 12). Systematic reviews have found a significant association between H. pylori infection and depleted iron stores, as well as improvements in serum ferritin and haemoglobin levels following H. pylori eradication therapy(13, 14).
Australia has one of the highest intake rates of refugee or refugee-like backgrounds. The prevalence of H. pylori infection in refugees in Australia is 1.5 times higher than in the general Australian population(15). Current Australian guidelines recommend that all refugees undergo a comprehensive health assessment within 12 months of arrival, including screening for anaemia, vitamin B12, and vitamin D deficiency(16), H. pylori screening is not routinely performed unless symptoms are present (e.g., dyspepsia or peptic ulcer disease) or presence of a family history of gastric cancer(16, 17). This approach aims to reduce overtreatment and address concerns about decreased treatment efficacy due to antibiotic resistance(18). However, H. pylori testing is recommended in cases of unexplained iron deficiency anaemia and vitamin B12 deficiency(17).
Theoretical/Conceptual Framework
Given that H. pylori disrupts gastric function, and potentially impairs nutrient absorption, (e.g., iron, vitamin B12, and D), and that refugees, especially those from conflict-ridden regions, face a higher risk of malnutrition due to limited access to nutritious food and healthcare, there is a need to examine the role of H. pylori in exacerbating these micronutrient deficiencies. Current Australian health guidelines do not mandate routine screening for H. pylori in asymptomatic refugees, potentially overlooking a key factor to malnutrition in this vulnerable population. Therefore, this study aims to clarify the role of H. pylori in exacerbating micronutrient deficiencies (vitamin B12, vitamin D, and iron) in Ezidi refugees resettling in rural Australia. This retrospective cohort study will inform potential changes to refugee health screening practices, addressing both infectious and nutritional challenges in this vulnerable population.
Methods
Participants
All available Ezidi refugee data from the Armidale Medical Practice and the Armidale Hospital initial refugee health assessment were included in this clinical cohort study. Individuals underwent H. pylori testing only if they met specific criteria:
Symptomatic individuals: those presenting with symptoms such as epigastric pain, fatigue, or bloating.
Micronutrient-deficient individuals: those with low iron or vitamin B12 levels, as identified through routine blood tests.
Family members of H. pylori-positive individuals: those tested due to a confirmed H. pylori infection in a household member.
This targeted approach aligns with real-world clinical decision-making and follows Australian guidelines; however, it limits generalisability, as it may overestimate the true prevalence of H. pylori in the broader Ezidi refugee population.
Data Collection
Patient data were extracted from two healthcare settings serving Ezidi refugees in Armidale: the Armidale Medical Centre and the Armidale Hospital. The Armidale Hospital primarily conducted initial refugee health assessments upon arrival, while the Armidale Medical Centre provided ongoing general practice care, including further investigations and management for symptomatic individuals or those with more complex clinical needs. As such, H. pylori testing was more commonly initiated in the general practice setting based on clinical presentation.
Data included demographic variables (date of birth, gender), H. pylori testing and treatment details, and levels of ferritin, vitamin D, and vitamin B12 (pre- and post-treatment (At least 6 weeks after the H. pylori therapy, including clarithromycin, amoxicillin, and esomeprazole triple therapy for 7–14 days per Australian guidelines). Following extraction, the data were de-identified, reviewed for completeness and accuracy, and analysed. This protocol was approved by the University of New England Ethical Committee (HE23-144). As this was a retrospective audit of de-identified data, the requirement for informed consent was waived in accordance with the National Statement on Ethical Conduct in Human Research (Australia, 2007). Prospective studies could benefit from the inclusion of a comparison group to better understand the relationship between H. pylori infection and micronutrient deficiencies.
Measures
Three different commercial pathology laboratories within the Armidale region conducted blood tests for each micronutrient deficiency at Armidale Medical Centre. The blood tests at Armidale Hospital were collected at the onsite pathology lab and transported to Sydney for analysis. All laboratories measured vitamin D concentration using the Diasorin method (imprecision rate of 5.2% or less)(19). Chemiluminescence and the Siemens method (detection limit: 125 pg/mL–2.2 pg/mL) were used for vitamin B12 levels (20). Ferritin concentration was measured using chemiluminescence microparticle immunoassay (CMIA) (sensitivity ≤ 1.0 ng/mL (21) and the Siemens method (detection limit ≤ 1.0 ng/mL)(22). These methods are consistent with current Australian clinical standards and provided reliable data.
According to clinical Australian guidelines and for practical considerations, H. pylori infection was identified by urea breath testing (UBT) using the Tri-Med PYtest kit for patients over 14 years old, and stool PCR for those under 14 or when UBT was unsuitable, such as in cases of intellectual disability. Patients under 3 were not tested. UBT’s sensitivity and specificity are 96% and 93%, respectively (23) in adults, and 96.6% and 97.7% (24) in children over 6 years. Stool PCR shows a sensitivity of 92% and specificity of 96%(25).
Deficiency criteria for the study were ferritin < 30 µg/L, vitamin D < 50 nmol/L, and total serum B12 < 138 pmol/L in conjunction with low Active vitamin B12 level. B12 testing was performed on total serum B12 levels between 139–250 pmol/L, and Active B12 levels < 50 pmol/L were considered deficient. Post-treatment testing was conducted during follow-up appointments after the appropriate treatment per Australian therapeutic guidelines (oral or parenteral supplementation). In some instances, comprehensive testing of all variables didn’t occur. Many patients were lost to follow-up, primarily due to patient relocation. For the missing variables, patients were excluded from the analysis.
Data Analysis
The Jamovi software was used to calculate the prevalence rates of H. pylori infection and micronutrient deficiencies. Both the chi-squared test of association and Fisher’s Exact test were used to evaluate the association between H. pylori infection and micronutrient deficiencies in the clinical cohort and in a subgroup of participants < 16 years of age.
Results
Patients H. pylori Testing
A total of 260 Ezidi refugee patients (female (n = 156), male (n = 104) of all ages (ranging from 6 months to 75 years) in the Armidale Medical Practice database up until Jan 2024 were included for analysis.
As summarised in Fig. 1, 202 patients underwent H. pylori testing: 155 patients tested positive, 45 tested negative, 2 had equivocal results and 58 were not tested. Following H. pylori guideline-based treatment, 114 patients were retested: 27 remained positive, 82 tested negative, and 5 had equivocal results (Indeterminate H. pylori test results). Given that 157 patients had positive or equivocal results on initial testing, there is a follow-up gap for 43 patients who possibly relocated or failed to follow up. The “equivocal results” indicate “indeterminate H. pylori test results”. These cases involved borderline breath test results that could not definitively confirm infection status.
Fig. 1.
Flow diagram of H. pylori testing conducted at Armidale Medical Centre
Prevalence of Vitamin B12, Vitamin D, and Ferritin Before and After Treatment
Ferritin levels were tested in 230 patients, with 35.2% found to be deficient. After treatment, 125 were retested, and 24% remained deficient (Table 1).
Table 1.
Prevalence of iron, vitamin D and B12 deficiencies
| Organisation | Context of testing | Micronutrient deficiency | Counts | % of total |
|---|---|---|---|---|
| Iron (ferritin) deficiency | ||||
| Armidale Medical Centre | Pre-treatment | Yes | 81 | 35.2 |
| No | 149 | 64.8 | ||
| Post-treatment | Yes | 30 | 24.0 | |
| No | 95 | 76.0 | ||
| Armidale Hospital | Initial Refugee Health Assessment | Yes | 166 | 41.9 |
| No | 230 | 58.1 | ||
| Vitamin D deficiency | ||||
| Armidale Medical Centre | Pre-treatment | Yes | 183 | 79.6 |
| No | 47 | 20.4 | ||
| Post-treatment | Yes | 78 | 69.6 | |
| No | 34 | 30.4 | ||
| Armidale Hospital | Initial Refugee Health Assessment | Yes | 327 | 82.6 |
| No | 69 | 17.4 | ||
| Vitamin B12 deficiency | ||||
| Armidale Medical Centre | Pre-treatment | Yes | 113 | 50.7 |
| No | 110 | 49.3 | ||
| Post-treatment | Yes | 19 | 17.0 | |
| No | 93 | 83.0 | ||
| Armidale Hospital | Initial Refugee Health Assessment | Yes | 225 | 58.0 |
| No | 163 | 42.0 | ||
Of the 260 patients, 230 were tested for vitamin D deficiency, and 183 (79.6%) were found to be deficient. After supplementation, 112 were retested, with 78 (69.6%) still deficient (Table 1).
For vitamin B12 levels, 223 patients were tested, and 113 (50.7%) were found to be deficient. After receiving dietary advice and parenteral supplementation, 112 were retested, and 19 (17.0%) remained deficient (Table 1).
Separately, data from Armidale Hospital included 507 patients. Of these, ferritin levels were tested in 396 patients, with 166 (41.9%) found to be iron deficient. The same 396 were also tested for vitamin D deficiency, and 327 (82.6%) were found to be deficient. For vitamin B12, 388 were tested, with 225 (58.0%) found to be deficient.
Further focus study was obtained from data extracted from Armidale Medical Centre refugee patients:
Association Between Iron Deficiency and H. pylori Status
Serum ferritin was assessed in 197 of 202 patients tested for H. pylori before treatment. Among 153 H. pylori-positive patients, 53 (34.6%) were iron deficient. Among 42 H. pylori-negative patients, 14 (33.3%) were iron deficient (Table 2). Two patients had equivocal results, one was iron deficient, and the other was not. Statistical analysis showed no significant relationship between H. pylori status and iron deficiency both in the clinical cohort and the < 16-year-old subgroup (p-value = 0.887 on chi-squared test of association and 1.00 on Fisher’s exact test (Table 2); p value = 0.553 and 0.596 on chi-squared test and Fisher’s exact test respectively (Table 3)).
Table 2.
H. pylori status and iron deficiency before and after treatment
| Iron deficient (pre-treatment) | Iron deficient (post-treatment) | |||||
|---|---|---|---|---|---|---|
| H. pylori test result | Yes | No | Total | Yes | No | Total |
| Positive | 53 | 100 | 153 | 7 | 10 | 17 |
| Negative | 14 | 28 | 42 | 13 | 44 | 57 |
| Equivocal | 1 | 1 | 2 | 2 | 2 | 4 |
| Total | 68 | 129 | 197 | 22 | 56 | 78 |
| Tests of association | Pre-treatment | Post-treatment | ||
|---|---|---|---|---|
| Value | p | Value | p | |
| χ2 | 0.239 | 0.887 | 3.17 | 0.205 |
| Fisher's exact test | 1 | 0.181 | ||
Table 3.
H. pylori status and iron deficiency before and after treatment in children < 16 years of age
| Children < 16 years | Iron deficient (pre-treatment) | Iron deficient (post-treatment) | ||||
|---|---|---|---|---|---|---|
| H. pylori test result | Yes | No | Total | Yes | No | Total |
| Positive | 15 | 41 | 56 | 5 | 2 | 7 |
| Negative | 8 | 16 | 24 | 3 | 14 | 17 |
| Total | 23 | 57 | 80 | 8 | 16 | 24 |
| Tests of association | Pre-treatment | Post-treatment | ||
|---|---|---|---|---|
| Value | p | Value | p | |
| χ2 | 0.352 | 0.553 | 6.45 | 0.011 |
| Fisher's exact test | 0.596 | 0.021 | ||
After H. pylori treatment, serum ferritin was assessed in 78 patients. Among 17 patients who remained H. pylori positive, 7 (41.2%) had persistent iron deficiency. Among 57 patients who tested negative for H. pylori post-treatment, 13 (22.8%) remained iron deficient. Four patients had equivocal results, e.g. where the test was inconclusive, with two being iron deficient. The association between post-treatment H. pylori status and iron deficiency was not statistically significant (p-value = 0.181 on Fisher’s exact test). In the subgroup < 16-years-old, among the 7 patients that remained H. pylori positive post-treatment, 5 (71.4%) remained iron deficient. Among the 17 patients who tested negative for H. pylori post-treatment, 3 (17.6%) remained iron deficient (Table 2). Statistical analysis revealed a significant relationship between post-treatment H. pylori status and iron deficiency (p-value = 0.021 on Fisher’s exact test) (Table 3).
Association Between Vitamin D Deficiency and H. pylori Status
Serum vitamin D was assessed in 190 of 202 patients before H. pylori treatment. Among 148 H. pylori-positive patients, 117 (79.1%) were vitamin D deficient. Of the 40 H. pylori-negative patients, 32 (80%) were vitamin D deficient. Two patients had equivocal results, with one being vitamin D deficient. Statistical analysis showed no significant relationship between H. pylori status and vitamin D deficiency in both the clinical cohort and < 16-year-old subgroup (p-value = 0.554, 0.432 respectively) (Tables 4, 5).
Table 4.
H. pylori status and vitamin D deficiency before and after treatment
| Vitamin D deficient (pre-treatment) | Vitamin D deficient (post-treatment) | |||||
|---|---|---|---|---|---|---|
| Initial H. pylori test result | Yes | No | Total | Yes | No | Total |
| Positive | 117 | 31 | 148 | 13 | 4 | 17 |
| Negative | 32 | 8 | 40 | 37 | 18 | 55 |
| Equivocal | 1 | 1 | 2 | 3 | 1 | 4 |
| Total | 150 | 40 | 190 | 53 | 23 | 76 |
| Tests of association | Pre-treatment | Post-treatment | ||
|---|---|---|---|---|
| Value | p | Value | p | |
| χ2 | 1.04 | 0.596 | 0.576 | 0.75 |
| Fisher's exact test | 0.554 | 0.815 | ||
Table 5.
H. pylori status and Vitamin D deficiency before and after treatment in children < 16 years of age
| Children < 16 years | Vitamin D deficient (pre-treatment) | Vitamin D deficient (post-treatment) | ||||
|---|---|---|---|---|---|---|
| Initial H. pylori test result | Yes | No | Total | Yes | No | Total |
| Positive | 33 | 20 | 53 | 6 | 1 | 7 |
| Negative | 17 | 6 | 23 | 7 | 8 | 15 |
| Total | 50 | 26 | 76 | 13 | 9 | 22 |
| Tests of association | Pre-treatment | Post-treatment | ||
|---|---|---|---|---|
| Value | p | Value | p | |
| χ2 | 0.967 | 0.325 | 3.01 | 0.083 |
| Fisher's exact test | 0.432 | 0.165 |
After H. pylori treatment, serum vitamin D was assessed in 76 patients. Of the 17 patients who remained H. pylori positive, 13 (76.5%) were still vitamin D deficient. Among the 55 patients who tested negative for H. pylori post-treatment, 37 (66.7%) remained vitamin D deficient. Four patients had equivocal results, with three being vitamin D deficient. The relationship between post-treatment H. pylori status and vitamin D deficiency was not statistically significant in both groups (p-value = 0.815, 0.165 respectively) (Tables 4, 5).
Association Between Vitamin B12 Deficiency and H. pylori Status
Serum vitamin B12 was assessed in 190 of 202 patients before H. pylori treatment. Among 147 H. pylori-positive patients, 70 (47.6%) were vitamin B12 deficient. Of the 41 H. pylori-negative patients, 27 (65.9%) were vitamin B12 deficient. Two patients had equivocal results, both of whom were vitamin B12 deficient. Statistical analysis revealed a significant relationship between H. pylori status and vitamin B12 deficiency in the clinical cohort (p-value = 0.032) (Table 6) but not in the < 16-year-old subgroup (p-value = 0.142) (TTable 5).
Table 6.
H. pylori status and Vitamin B12 deficiency before and after treatment
| Vitamin B12 deficient (pre-treatment) | Vit B12 deficient (post-treatment) | |||||
|---|---|---|---|---|---|---|
| Initial H. pylori test result | Yes | No | Total | Yes | No | Total |
| Positive | 70 | 77 | 147 | 1 | 15 | 16 |
| Negative | 27 | 14 | 41 | 11 | 43 | 54 |
| Equivocal | 2 | 0 | 2 | 0 | 4 | 4 |
| Total | 99 | 91 | 190 | 12 | 62 | 74 |
| Tests of association | Pre-treatment | Post-treatment | ||
|---|---|---|---|---|
| Value | p | Value | p | |
| χ2 | 6.13 | 0.047 | 2.63 | 0.269 |
| Fisher's exact test | 0.032 | 0.425 | ||
After H. pylori treatment, serum vitamin B12 was assessed in 74 patients. Among 16 patients who remained H. pylori positive, 1 (6.7%) remained vitamin B12 deficient, and 15 (93.3%) were not. Among 54 patients who tested negative for H. pylori post-treatment, 11 (20.4%) remained vitamin B12 deficient, and 43 (79.6%) were not. Four patients had equivocal results, none of whom were vitamin B12 deficient. The relationship between vitamin B12 deficiency and H. pylori status post-treatment was not statistically significant in both groups (p-value = 0.425, 1.000 respectively) (Tables 6, 7).
Table 7.
H. pylori status and Vitamin B12 deficiency before and after treatment in children < 16 years of age
| Children < 16 years | Vitamin B12 deficient (pre-treatment) | Vit B12 deficient (post-treatment) | ||||
|---|---|---|---|---|---|---|
| Initial H. pylori test result | Yes | No | Total | Yes | No | Total |
| Positive | 22 | 29 | 51 | 1 | 6 | 7 |
| Negative | 15 | 9 | 24 | 3 | 12 | 15 |
| Total | 37 | 38 | 75 | 4 | 18 | 22 |
| Tests of association | Pre-treatment | Post-treatment | ||
|---|---|---|---|---|
| Value | p | Value | P | |
| χ2 | 2.45 | 0.118 | 0.105 | 0.746 |
| Fisher's exact test | 0.142 | 1.000 | ||
Discussion
Prevalence of H. pylori Infection
The prevalence of H. pylori infection in Ezidi refugees was 76.7%. This is significantly higher than the global rates (43.9% in adults, 35.1% in children) (26)and higher than the rates reported in Iraq (54.2% in adults, 37.1% in children)(26). This is consistent with other studies reporting H. pylori prevalence between 72 – 93% in refugees and immigrants in Western countries(27). However, it exceeds the 21.5% prevalence observed among newly arrived refugees in South Australia(15). The high rates of H. pylori infection among Ezidi refugees may be linked to environmental and social factors such as overcrowding, poor sanitation, large family sizes, and food sharing, conditions that facilitate transmission. These issues are common in refugee settings and have been associated with increased H. pylori risk in other refugee populations, including those in South Australia(15). Limited access to healthcare in camps further compounds these risks. Further research is needed to disentangles these overlapping factors.
Iron Deficiency and H. pylori Infection
Iron deficiency was similar in both study samples (41.9% at Armidale Hospital and 35.2% at Armidale Medical Centre). This is notably higher than the Australian general population (35, 36). Overall, our study found no statistically significant association between H. pylori and iron deficiency as measured by serum ferritin, in contrast to several studies that report a significant association between H. pylori infection and iron deficiency(14, 28–30), as well as improvements in serum ferritin following H. pylori eradication(14, 28–30). However, a subgroup analysis of children < 16-years-old demonstrated a statistically significant association between persistent H. pylori infection post eradication therapy and persistent iron deficiency. Likewise, the association between a negative H. pylori status post-treatment and absence of iron deficiency was statistically significant. This result suggests that successful H. pylori eradication may improve iron status in iron deficient children, however, this was seen in a small sample size. Similar findings have been observed in other studies examining the relationship between H. pylori and iron deficiency in children (13, 31, 32). However, persistent iron deficiency or anaemia has been observed for up to two years post H. pylori eradication(33), raising the possibility of persisting gastritis impacting iron levels after H pylori eradication.
Kishore et al. reported higher serum ferritin levels in H. pylori-infected individuals compared to the uninfected group(34). A physiological immune defence mechanism, which increases iron storage and ferritin levels during infectious diseases and inflammation to limit bacterial access to needed iron for growth, may explain this(35). Since we could only rely on measured serum ferritin levels to assess iron deficiency, this mechanism may explain our non-statistically significant results. It is possible that the inflammatory response caused by H. pylori infection led to normal or increased serum ferritin levels in our study cohort, masking an underlying iron deficiency. Future research investigating the impact of H. pylori on iron deficiency and iron deficiency anaemia should include additional parameters such as a haemoglobin concentration, mean corpuscular volume, mean corpuscular haemoglobin, total iron binding capacity, ferritin, transferrin, and transferrin saturation.
Vitamin B12 Deficiency and H. pylori Infection
Vitamin B12 deficiency was high in both samples (58% at Armidale Hospital, 50.7% at Armidale Medical Centre), exceeding the rates seen in the general Australian population (0.9–2.8%)(36). These rates are even higher than vulnerable populations such as the elderly (14%) and vegans (26%)(37, 38). In comparison, a study that also examined refugees from a similar Middle Eastern background revealed a 16.5% prevalence rate(39).
Interestingly, our study found that Ezidi refugees without H. pylori infection were more likely to be vitamin B12 deficient than those with H. pylori infection, both before and after eradication therapy. This suggests that H. pylori may have a minor protective effect against vitamin B12 deficiency. These findings are inconsistent with previous studies, some of which report no association between H. pylori and vitamin B12 levels(10), while others identify H. pylori infection as a significant risk factor for vitamin B12 deficiency(10, 40, 41).
H. pylori is known to cause atrophic gastritis and destruction of gastric parietal cells(41), leading to impaired stomach acidification and reduced intrinsic factor secretion, both of which are required for vitamin B12 transport and absorption(10, 42). The higher rate of vitamin B12 deficiency in H. pylori-negative individuals in our study is surprising, as previous research findings align more with vitamin B12 malabsorption mechanisms(8, 43, 44). To explore potential autoimmune causes, blood tests for intrinsic factor and parietal cell antibodies were ordered for all B12-deficient refugees, with only one patient returning a positive result for gastric parietal cell antibodies.
Lifestyle factors and comorbid medical conditions may have influenced the vitamin B12 levels observed, but establishing an association between those components is beyond the scope of this study. Among patients who were both H. pylori positive and vitamin B12 deficient, we found a rate of 47.6%, which is close to rates reported in previous studies(8, 40, 44). Additionally, we observed a decrease in the prevalence of vitamin B12 deficiency from 52.1% to 16.2% after treatment. However, there was a significant number of missing follow-up data, which does introduce some bias.
Vitamin D Deficiency and H. pylori Infection
Vitamin D deficiency was similar in both study samples (79.6% at Armidale Medical Centre, 82.6% at Armidale Hospital), closely matching a previously reported rate of 89% in Middle Eastern refugees(45). Nevertheless, this is significantly higher than the approximately 23% prevalence reported in the Australian population (46). The high prevalence observed in our study may attributed to factors such as the wearing of conservative clothing (scarves or hijabs) and a cultural aversion to tanning.
Our study found no statistically significant link between H. pylori infection and vitamin D deficiency, either pre- or post-treatment. As of today, the relationship between these two factors remains unclear(12). However, some studies suggest that vitamin D may act as a protective factor against H. pylori infection, potentially improving the success of eradication therapy (12, 47) but further studies are required to establish a connection between H. pylori infection, vitamin D deficiency, supplementation, and its impact on H. pylori treatment(48).
Limitations
Several limitations must be acknowledged. The small sample size of Ezidi refugees in Armidale reduces the study's statistical power. The data extraction process using Best Practice software compared to manual extraction may have introduced inconsistencies, however the data were double-checked by two collectors. The selective nature of pathology testing, based on clinical suspicion, introduces sampling bias, potentially inflating prevalence rates. Additionally, the use of multiple commercial laboratories for pathology testing may have caused minor detection bias. However, this bias is likely limited, as deficiency rates were similar between the Armidale Medical Centre and the Armidale Hospital.
Due to the nature of the data available, the inclusion of a control group was not feasible in this study.
Variable treatment durations and inconsistent follow-up times may also influence post-treatment prevalence rates due to bias. Moreover, data on treatment eradication outcomes, such as H. pylori eradication, were not available. This is a notable limitation, as previous research in other immigrant populations suggests eradication rates are often lower than the general population. We recommend that future studies specifically collect and evaluate these outcomes.
The study did not fully account for confounding factors such as age, comorbidities, and diet, which could have affected the results. For example, polyphenol-containing beverages like tea and coffee significantly reduce iron absorption, and conditions like coeliac disease are known to cause micronutrient deficiencies due to malabsorption. Finally, the retrospective nature of the study, relying on past records, may have resulted in incomplete data.
Inclusion of additional micronutrient markers would have strengthened our analysis. However, these tests were not routinely conducted in the clinical setting for this cohort as per Australian clinical guidelines, and were therefore not available for retrospective analysis.
Contribution to the Literature
This is the first study to asses and compare the prevalence of H. pylori, iron deficiency, vitamin B12 deficiency, and vitamin D deficiency among Ezidi refugees in Armidale, a rural Australian town selected for regional settlement through a specialised program (49). The study found no significant correlation between H pylori infection, iron and vitamin D deficiencies, but it did observe a significant association between vitamin B12 deficiency and H. pylori-negative individuals. A significant association of post-treatment H. pylori infection status and iron deficiency was observed in children in a small sample size. The overall relationship between H. pylori infection and micronutrient deficiencies remains unclear, as previous studies have reported mixed and inconsistent results. This study emphasises the need for further research to clarify these associations and supports the potential for standardised screening protocols for Ezidi refugees.
Acknowledgements
To Armidale Medical Centre and Armidale Rural Referral Hospital Mr Ashley Young and team extracted and provided data for patients at Armidale Hospital.
Author Contributions
S.A. acquired the data. G.N. primarily extracted the data. E.H, O.M, G.N, and N.T equally analysed the data under the joint supervision of S.A and J.C. E.H, O.M, G.N, and N.T contributed equally to the first draft of the manuscript, while S. A and J.C. revised it. This paper adheres to the STROBE Checklist: cohort, case–control, and cross-sectional studies (combined) (available upon request).
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions. No funding was received for this research.
Data Availability
Unidentified data will be provided if needed, it is saved at Armidale Medical Centre patient confidential file.
Declarations
Competing interests
There is no competing interest to disclose.
Informed Consent
All authors consent for publication.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori: commensal, symbiont or pathogen? World J Gastroenterol. 2021;27(7):545–60. 10.3748/wjg.v27.i7.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Boyanova L, Hadzhiyski P, Gergova R, Markovska R. Evolution of Helicobacter pylori resistance to antibiotics: a topic of increasing concern. Antibiotics (Basel). 2023. 10.3390/antibiotics12020332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113–21. 10.1136/gutjnl-2020-320839. [DOI] [PubMed] [Google Scholar]
- 4.Khuri J, Wang Y, Holden K, Fly AD, Mbogori T, Mueller S, et al. Dietary intake and nutritional status among refugees in host countries: a systematic review. Adv Nutr. 2022;13(5):1846–65. 10.1093/advances/nmac051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Coumans JVF, Wark S. A scoping review on the barriers to and facilitators of health services utilisation related to refugee settlement in regional or rural areas of the host country. BMC Public Health. 2024;24(1):199. 10.1186/s12889-024-17694-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Beukeboom C, Arya N. Prevalence of nutritional deficiencies among populations of newly arriving government assisted refugee children to Kitchener/Waterloo, Ontario. Canada J Immigr Minor Health. 2018;20(6):1317–23. 10.1007/s10903-018-0730-9. [DOI] [PubMed] [Google Scholar]
- 7.Australian Bureau of Statistics. National Health Measures Survey, 2022–24. Australian Bureau of Statistics; 2025.
- 8.Kaptan K, Beyan C, Ural AU, Cetin T, Avcu F, Gülşen M, et al. Helicobacter pylori—is it a novel causative agent in Vitamin B12 deficiency? Arch Intern Med. 2000;160(9):1349–53. 10.1001/archinte.160.9.1349. [DOI] [PubMed] [Google Scholar]
- 9.Nabavi-Rad A, Azizi M, Jamshidizadeh S, Sadeghi A, Aghdaei HA, Yadegar A, et al. the effects of vitamins and micronutrients on Helicobacter pylori pathogenicity, survival, and eradication: a crosstalk between micronutrients and immune system. J Immunol Res. 2022;2022:4713684. 10.1155/2022/4713684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Cai X, Li X, Jin Y, Zhang M, Xu Y, Liang C, et al. Vitamins and Helicobacter pylori: an updated comprehensive meta-analysis and systematic review. Front Nutr. 2021;8: 781333. 10.3389/fnut.2021.781333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shafrir A, Shauly-Aharonov M, Katz LH, Paltiel O, Pickman Y, Ackerman Z. The association between serum vitamin D levels and Helicobacter pylori presence and eradication. Nutrients. 2021. 10.3390/nu13010278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yang L, He X, Li L, Lu C. Effect of vitamin D on Helicobacter pylori infection and eradication: a meta-analysis. Helicobacter. 2019;24(5): e12655. 10.1111/hel.12655. [DOI] [PubMed] [Google Scholar]
- 13.Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017. 10.1111/hel.12330. [DOI] [PubMed] [Google Scholar]
- 14.Mulayamkuzhiyil Saju J, Mandal N, Kham NI, Shahid R, Naik SS, Ramphall S, et al. Is Helicobacter Pylori a reason for unexplained iron deficiency anemia: a systematic review. Cureus. 2022;14(9): e29112. 10.7759/cureus.29112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Abdul Rahim NR, Benson J, Grocke K, Vather D, Zimmerman J, Moody T, et al. Prevalence of Helicobacter pylori infection in newly arrived refugees attending the Migrant Health Service. South Australia Helicobacter. 2017. 10.1111/hel.12360. [DOI] [PubMed] [Google Scholar]
- 16.Recommendations for Comprehensive Post-Arrival Health Assessment for people from Refugee-like backgrounds 2016. Available from: https://asid.au/products/refugee-guidelines-2016.
- 17.Chaves NPG. Recommendations for comprehensive post-arrival health assessment for people from refugee-like backgrounds - anaemia, iron deficiency and other blood conditions: Refugee Health Network of Australia; 2016. Available from: https://www.rch.org.au/uploadedFiles/Main/Content/immigranthealth/ASID-RHeaNA%20screening%20guidelines.pdf.
- 18.Thomas Schulz MK, Cherian S. Helicobacter Pylori 2016. Available from: https://refugeehealthguide.org.au/helicobacter-pylori/.
- 19.Fraser WD, Tang JCY, Dutton JJ, Schoenmakers I. Vitamin D measurement, the debates continue, new analytes have emerged, developments have variable outcomes. Calcif Tissue Int. 2020;106(1):3–13. 10.1007/s00223-019-00620-2. [DOI] [PubMed] [Google Scholar]
- 20.Tsiminis G, Schartner EP, Brooks JL, Hutchinson MR. Measuring and tracking vitamin B12: a review of current methods with a focus on optical spectroscopy. Appl Spectrosc Rev. 2017;52(5):439–55. 10.1080/05704928.2016.1229325. [Google Scholar]
- 21.National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices. 2nd ed. National Committee for Clinical Laboratory Standards; 1992.
- 22.Clinical and Laboratory Standards Institute. Evaluation of detection capability for clinical laboratory measurement procedures; Approved guideline. 2nd ed. Wayne: Clinical and Laboratory Standards Institue; 2012.
- 23.Ferwana M, Abdulmajeed I, Alhajiahmed A, Madani W, Firwana B, Hasan R, et al. Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis. World J Gastroenterol. 2015;21(4):1305–14. 10.3748/wjg.v21.i4.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Leal YA, Flores LL, Fuentes-Pananá EM, Cedillo-Rivera R, Torres J. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a systematic review and meta-analysis. Helicobacter. 2011;16(4):327–37. 10.1111/j.1523-5378.2011.00863.x. [DOI] [PubMed] [Google Scholar]
- 25.Zhang Q, Yang S, Zhou J, Li Z, Wang L, Dong Q. Diagnostic accuracy of stool sample-based PCR in detecting Helicobacter pylori infection: a meta-analysis. Journal of Laboratory Medicine. 2023;47(5):187–97. 10.1515/labmed-2023-0004. [Google Scholar]
- 26.Chen Y-C, Malfertheiner P, Yu H-T, Kuo C-L, Chang Y-Y, Meng F-T, et al. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology. 2024;166(4):605–19. 10.1053/j.gastro.2023.12.022. [DOI] [PubMed] [Google Scholar]
- 27.Schulz T, Kay M, Cherian S. Recommendations for comprehensive post-arrival health assessment for people from refugee-like backgrounds—Helicobacter pylori: Refugee Health Network of Australia; 2016. Available from: https://refugeehealthguide.org.au/helicobacter-pylori/#:~:text=Routine%20screening%20for%20Helicobacter%20pylori,recommended%20(EBR%20%E2%80%93%20C3).&text=Screening%20with%20either%20stool%20antigen,adults%20from%20high%2Drisk%20groups.
- 28.Ha MT, Le VT, Huynh PD, Nguyen TA. Anemia among active Helicobacter pylori infection at the University Medical Center Ho Chi Minh City: a case–control study. Medicina Clínica Práctica. 2024. 10.1016/j.mcpsp.2023.100423. [Google Scholar]
- 29.Mubaraki MA, Alalhareth AS, Aldawood E, Albouloshi A, Aljarah MS, Hafiz TA, et al. The iron deficiency anemia in association to Helicobacter pylori infection in Najran city, Saudi Arabia. J King Saud Univ Sci. 2022;34(8): 102353. 10.1016/j.jksus.2022.102353. [Google Scholar]
- 30.Zuberi BF, Afsar S, Qadeer R, Baloch I, Quraishy MS, Kumar A, et al. Hemoglobin, ferritin, vitamin B12 and Helicobacter pylori infection: a study in patients who underwent upper GI endoscopy at civil hospital Karachi. J Coll Physicians Surg Pak. 2007;17(9):546–9. [PubMed] [Google Scholar]
- 31.Kato S, Gold BD, Kato A. Helicobacter pylori-associated iron deficiency anemia in childhood and adolescence-pathogenesis and clinical management strategy. J Clin Med. 2022. 10.3390/jcm11247351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lupu A, Miron IC, Cianga AL, Cernomaz AT, Lupu VV, Munteanu D, et al. The relationship between anemia and Helicobacter pylori infection in children. Children (Basel). 2022. 10.3390/children9091324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hou B, Zhang M, Liu M, Dai W, Lin Y, Li Y, et al. Association of active Helicobacter pylori infection and anemia in elderly males. BMC Infect Dis. 2019;19(1):228. 10.1186/s12879-019-3849-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kishore G, Ejaz M, Kumar J, Lal A, Tahir H, Anjum Z, et al. Association between Helicobacter pylori infection and serum iron profile. Cureus. 2021;13(9): e17925. 10.7759/cureus.17925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401–9. 10.1093/intimm/dxx031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Seifu CN, Fahey PP, Atlantis E. Micronutrient deficiencies and anaemia associated with body mass index in Australian adults: a cross-sectional study. BMJ Open. 2022;12(12): e061442. 10.1136/bmjopen-2022-061442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Mirkazemi C, Peterson GM, Tenni PC, Jackson SL. Vitamin B12 deficiency in Australian residential aged care facilities. J Nutr Health Aging. 2012;16(3):277–80. 10.1007/s12603-011-0348-2. [DOI] [PubMed] [Google Scholar]
- 38.Benham AJ, Gallegos D, Hanna KL, Hannan-Jones MT. Intake of vitamin B(12) and other characteristics of women of reproductive age on a vegan diet in Australia. Public Health Nutr. 2021;24(14):4397–407. 10.1017/s1368980021001695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Benson J, Phillips C, Kay M, Webber MT, Ratcliff AJ, Correa-Velez I, et al. Low vitamin B12 levels among newly-arrived refugees from Bhutan, Iran and Afghanistan: a multicentre Australian study. PLoS ONE. 2013;8(2): e57998. 10.1371/journal.pone.0057998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ali U, Abbasi W, Huda N. Vitamin B12 Deficiency among cases of Helicobacter pylori gastritis: a cross sectional study. Journal of Health and Rehabilitation Research. 2024;4:553–6. 10.61919/jhrr.v4i2.907
- 41.Krishnegowda R, Joseph J, Thomas D. Helicobacter pylori infection and vitamin B-12 deficiency—a cross sectional study. Asian Journal of Medical Sciences. 2017;8:16. 10.3126/ajms.v8i4.17280. [Google Scholar]
- 42.Gowdappa HB, Mahesh M, Murthy KV, Narahari MG. Helicobacter pylori associated vitamin B12 deficiency, pernicious anaemia and subacute combined degeneration of the spinal cord. BMJ Case Rep. 2013. 10.1136/bcr-2013-200380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Serin E, Gümürdülü Y, Ozer B, Kayaselçuk F, Yilmaz U, Koçak R. Impact of Helicobacter pylori on the development of vitamin B12 deficiency in the absence of gastric atrophy. Helicobacter. 2002;7(6):337–41. 10.1046/j.1523-5378.2002.00106.x. [DOI] [PubMed] [Google Scholar]
- 44.Sarari AS, Farraj MA, Hamoudi W, Essawi TA. Helicobacter pylori, a causative agent of vitamin B12 deficiency. J Infect Dev Ctries. 2008;2(5):346–9. 10.3855/jidc.194. [DOI] [PubMed] [Google Scholar]
- 45.Penrose K, Hunter Adams J, Nguyen T, Cochran J, Geltman PL. Vitamin D deficiency among newly resettled refugees in Massachusetts. J Immigr Minor Health. 2012;14(6):941–8. 10.1007/s10903-012-9603-9. [DOI] [PubMed] [Google Scholar]
- 46.Australian Bureau of Statistics. Australian Health Survey: Biomedical Results for Nutrients, 2011–12: Vitamin D 2013. Available from: https://www.abs.gov.au/articles/vitamin-d.
- 47.El Shahawy MS, Hemida MH, El Metwaly I, Shady ZM. The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection. JGH Open. 2018;2(6):270–5. 10.1002/jgh3.12081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Săsăran MO, Mărginean CO, Lupu A, Koller AM. Vitamin D and its association with H. pylori prevalence and eradication: a comprehensive review. Nutrients. 2023. 10.3390/nu15163549 [DOI] [PMC free article] [PubMed]
- 49.Australian Government Department of Home Affairs. Humanitarian Settlement Program: Humanitarian Settlement in Regional Australia; 2024. Available from: https://immi.homeaffairs.gov.au/settling-in-australia/humanitarian-settlement-program/about-the-program/humanitarian-settlement-regional-australia.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Unidentified data will be provided if needed, it is saved at Armidale Medical Centre patient confidential file.

